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To improve therapeutic efficiency,
cytotoxic agents are often used in com-
bination. In selecting agents for com-
bination therapy, those with similar
modes of action have generally been
avoided but recently agents which inhi-
bit DNA synthesis have been used
clinically in combination. Thus metho-
trexate, a folic acid analogue, and cytosine
arabinoside, a pyrimidine analogue, are
sometimes used together in the treat-
ment of acute leukaemia (Mathe et al.,
1971). In addition to being effective
drugs when used alone, or in combination
with certain other drugs, these 2 agents
share the inmportant property of being
suitable for intrathecal administration,
and this may seem a compelling reason
for using them together in the prophylaxis
or treatment of meningeal leukaemia.
We have been unable to find any
documented evidence for the effective-
ness ofmethotrexate and cytosine arabino-
side in combination and we have therefore
investigated their action in rats and mice,
using body weight and survival as indices
of activity.
Inbred male Wistar rats, aged 4-6
months and weighing 350-450 g, were
housed 3 per cage. The dosages of the
drugs, calculated individually for each
rat, were 1-0 or 2-0 mg/kg body weight
of methotrexate and 25 or 50 mg/kg of
cytosine arabinoside in 0-2 ml saline,
given 3 times daily intraperitoneally on
2 consecutive days. Controls received
saline injections on a similar schedule.
Inbred female CBA mice, weighing
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TABLE I.-Deaths and Weight Loss in
Surviving Rats Receiving Methotrexate
(MTX) and CytosineArabinoside (CA)
Alone or in Combination
Group Drug dosage
1 Saline Control
2 MTX 1 mg/kg x 6
3 CA 25mg/kg x 6
4 MTX 1 mg/kg x 6
CA 25 mg/kg x 6
5 MTX 2mg/kg x 6
6 CA 50mg/kg x 6
7 MTX2mg/kg x 6
CA 50mg/kIg x 6
Surviving
animals
Max.
weight
deficit
No. of (% of
rats Deaths initial wt)
6 0 3.5
9 3 11-6
9 0 3-5
9 0 8-3
18 16 21- 9
18 0 6-1
18 7 13-3
22-26 g and aged 3-4 months, were
housed 5 per cage and received feed and
water ad libitum. Groups of 10 mice were
matched for weight and age, and were
weighed daily. Methotrexate, 10 mg/kg
and/or cytosine arabinoside, 25 mg/kg,
were injected intraperitoneally 3 times
daily on 2 consecutive days. A control
group received saline on a similar schedule.
The results of the rat experinments are
summarized in Table I.
The difference between the metho-
trexate group and the methotrexate
plus cytosine arabinoside group is signifi--
cant (P =< 0-01). At both dose levels
tested, weight loss was greater in the
group which received methotrexate alone
than in the group which received the same
dose of methotrexate together with cyto-
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TABLE II.-Deaths and Weight Loss in Surviving CBA Mice Receiving Methotrexate
(MTX) Alone or in Combination with Cytosine Arabinoside (CA)
Surviving animals Surviving animals
Weight Day 7 Weight Day 13
No. ofmice Deaths % initial wt % initial wt
Saline control 10 0 -3*2 +1 2
MTX 1mg/kg x 6 10 0 -15-4 -11.0
CA 25 mg/kg x 6 10 0 -6-4 +1-8
MTX 1 mg/kg x 6 10 1 -17*5 +0*2
CA 25 mg/kg x 6
The results of the experiments in
mice are summarized in Table II.
These observations suggest that the
effects of the antimetabolite, metho-
trexate, which interferes with DNA
synthesis, may be lessened rather than
increased by the concurrent administra-
tion of another inhibitor of DNA syn-
thesis, cytosine arabinoside. This effect
may show species variability. We have
no evidence bearing on the mechanism
underlying the protection which cytosine
arabinoside appears to afford the rat
against the effects of methotrexate.
Roberts and Loehr (1971) have studied
the action of these drugs on thymidylate
synthetase activity in a human lympho-
blastic cell line in culture and found that
whereas methotrexate elevated the level
of thymidylate synthetase activity in the
culture medium, itwasloweredbycytosine
arabinoside and intermediate values were
found when both agents were present.
Although the present experiments
provide no evideince for the effect of this
drug combination on neoplastic cells, it
would seem unjustified to assume that the
drug combination behaves differently
with respect to normal and neoplastic
cells. Our evidence suggests that simul-
taneous administration of 2 metabolic
antagoinists does not necessarily produce
as great an effect as that produced by a
single agent, and also that significant
antagonism may occur.
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